[New oral anticoagulants and prostate biopsy: Which usual precaution should we use?].
Fiche publication
Date publication
juillet 2015
Journal
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NGUYEN Philippe
Tous les auteurs :
Coscarella M, Viart L, Nguyen P, Saint F
Lien Pubmed
Résumé
In 2013, more than 30,000 prostate biopsies have been performed in France. Bleeding complications are not rare. It imposes meticulous perioperative management in order to avoid them. In a close future, new oral anticoagulants (NOAC) will probably substitute vitamin K antagonist in many indications. The management of these new drugs is not really familiar in urology. The authors have specified it by using a systematic literature search in association to guidelines analysis edited by learned society.
Mots clés
Administration, Oral, Anticoagulants, administration & dosage, Biopsy, Drug Administration Schedule, Hemorrhage, etiology, Humans, Male, Perioperative Care, Practice Guidelines as Topic, Prostate, pathology
Référence
Prog. Urol.. 2015 Jul;25(9):510-5